|
San Francisco General Hospital
Table of Contents
February 1996 CLINICAL CARE
Does PCP Prophylaxis Improve Survival in Patients with HIV Infection?New data suggest new approaches to clinical managementNEIL M.H. GRAHAM, M.B.B.S., M.D., M.P.H.
NEWSLINE Newsline ... Newsline ... Newsline ...Two studies establish efficacy of ritonavir: New protease inhibitor has prompt and potent antiretroviral activity ... Ritonavir prevents disease progression and prolongs life: First evidence of the clinical benefit of protease inhibition ... Potent, sustained antiviral activity of ZDV and 3TC combined with indinavir: Most powerful drug combination yet studied
OPTIMAL MEDICAL MANAGEMENT Coccidioidomycosis and HIV DiseaseClinical manifestations, and effective treatment, of an endemic infectionJON E. LUTZ, M.D., DAVID A. STEVENS, M.D., GEORGE A. SAROSI, M.D. This article was provided by San Francisco General Hospital. It is a part of the publication HIV Newsline. |